Comparison of 12-W Versus 14-W Endovenous Laser Ablation in the Treatment of Great Saphenous Varicose Veins

Abstract

Introduction:

Endovenous laser ablation (EVLA) has been demonstrated to be an effective treatment for lower limb varicose veins in the short and midterm results. This study reports the 5-year outcomes of EVLA technique at different power settings.

Methods:

Patients with primary symptomatic, unilateral varicose veins secondary to saphenofemoral junction (SFJ) incompetence and great saphenous vein (GSV) reflux were recruited and randomized to either 12W (intermittent laser withdrawal) or 14W (continuous laser withdrawal). They were assessed at baseline, 1, 6, 12, 52, 104 weeks, and 5 years. Outcome measures included: Venous Clinical Severity Score (VCSS), pain scores, time taken to return to normal functions, complications, recurrence, quality of life (QoL), and duplex ultrasound findings.

Results:

76 consecutive patients, M: F 30:46, median age 54(IQR: 37.3-59) years were randomized.

Intragroup analysis:

Significant improvement was seen in both groups in VCSS, pain scores, Aberdeen varicose vein questionnaire (AVVQ) scores, Shortform-36 (SF-36) and Euroqol (EQ-5D) domains over the follow-up period (P < 0.05).

Intergroup analysis:

Over 5 years, clinically recurrent varicosities and duplex detected SFJ incompetence was less frequent and patient satisfaction with cosmetic outcome significantly higher in the 14W group (P < 0.05). There was no significant difference between the groups in duration of procedure, postoperative pain scores, return to normal functioning, complications, VCSS, disease specific (AVVQ) and generic (SF36, EQ-5D) QoL measures (P > 0.05).

Conclusion:

Late outcomes following EVLA were superior for the 14W continuous power settings achieving better long term venous occlusion and lowered recurrence rates without increasing post-operative morbidity. Hence 14W continuous setting should be the energy delivery mode of choice.

Keywords

varicose veins endovenous laser ablation laser energy venous clinical severity score quality of life

Get full access to this article

View all access options for this article.

References

Min

Khilnani

Zimmet

. Endovenous laser treatment of saphenous vein reflux: long-term results. J Vasc Interv Radiol. 2003;14(8):991–996.

van den Bos

Arends

Kockaert

Neumann

Nijsten

. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg. 2009;49(1):230–239.

Luebke

Brunkwall

. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cardiovasc Surg. 2008;49(2):213–233.

Van Den Bos

Neumann

De Roos

Nijsten

. Endovenous laser ablation-induced complications: review of the literature and new cases. Dermatol Surg. 2009;35(8):1206–1214.

Leopardi

Hoggan

Fitridge

Woodruff

Maddern

. Systematic review of treatments for varicose veins. Ann Vasc Surg. 2009;23(2):264–276.

Mundy

Merlin

Fitridge

Hiller

. Systematic review of endovenous laser treatment for varicose veins. Br J Surg. 2005;92(10):1189–1194.

Garratt

Macdonald

Ruta

Russell

Buckingham

Krukowski

. Towards measurement of outcome for patients with varicose veins. Qual Health Care. 1993;2(1):5–10.

Smith

Garratt

Guest

Greenhalgh

Davies

. Evaluating and improving health-related quality of life in patients with varicose veins. J Vasc Surg. 1999;30(4):710–719.

Garratt

Ruta

Abdalla

Russell

. Responsiveness of the SF-36 and a condition-specific measure of health for patients with varicose veins. Qual Life Res. 1996;5(2):223–234.

10.

Eklof

Rutherford

Bergan

. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248–1252.

11.

Beebe

Bergan

Bergqvist

. Classification and grading of chronic venous disease in the lower limbs. A consensus statement. Eur J Vasc Endovasc Surg. 1996;12(4):487–491; discussion 491-492.

12.

Kakkos

Rivera

Matsagas

. Validation of the new venous severity scoring system in varicose vein surgery. J Vasc Surg. 2003;38(2):224–228.

13.

Rutherford

Padberg

Jr Comerota

Kistner

Meissner

Moneta

. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000;31(6):1307–1312.

14.

Meissner

Natiello

Nicholls

. Performance characteristics of the venous clinical severity score. J Vasc Surg. 2002;36(5):889–895.

15.

Garratt

Ruta

Abdalla

Russell

. SF 36 health survey questionnaire: II. Responsiveness to changes in health status in four common clinical conditions. Qual Health Care. 1994;3(4):186–192.

16.

Brazier

Roberts

Deverill

. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–292.

17.

Dolan

Gudex

Kind

Williams

. The time trade-off method: results from a general population study. Health Econ. 1996;5(2):141–154.

18.

Brazier

Jones

Kind

. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2(3):169–180.

19.

Brooks

. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.

20.

EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16(3):199–208.

21.

Michaels

Campbell

Brazier

. Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). Health Technol Assess. 2006;10(13):1–196, iii–iv.

22.

Weiss

. Comparison of endovenous radiofrequency versus 810 nm diode laser occlusion of large veins in an animal model. Dermatol Surg. 2002;28(1):56–61.

23.

Bush

Shamma

, Hammond KA. 940-nm laser for treatment of saphenous insufficiency: histological analysis and long-term follow-up. Photomed Laser Surg. 2005;23(1):15–19.

24.

Theivacumar

Dellagrammaticas

Beale

Mavor

Gough

. Factors influencing the effectiveness of endovenous laser ablation (EVLA) in the treatment of great saphenous vein reflux. Eur J Vasc Endovasc Surg. 2008;35(1):119–123.

25.

Proebstle

Krummenauer

Gul

Knop

. Nonocclusion and early reopening of the great saphenous vein after endovenous laser treatment is fluence dependent. Dermatol Surg. 2004;30(2 pt 1):174–178.

26.

Timperman

Sichlau

Ryu

. Greater energy delivery improves treatment success of endovenous laser treatment of incompetent saphenous veins. J Vasc Interv Radiol. 2004;15(10):1061–1063.

27.

De Felice

. Shedding light: laser physics and mechanism of action. Phlebology. 2010;25(1):11–28.

28.

Proebstle

Moehler

Herdemann

. Reduced recanalization rates of the great saphenous vein after endovenous laser treatment with increased energy dosing: definition of a threshold for the endovenous fluence equivalent. J Vasc Surg. 2006;44(4):834–839.

29.

Timperman

. Prospective evaluation of higher energy great saphenous vein endovenous laser treatment. J Vasc Interv Radiol. 2005;16(6):791–794.

30.

Perkowski

Ravi

Gowda

. Endovenous laser ablation of the saphenous vein for treatment of venous insufficiency and varicose veins: early results from a large single-center experience. J Endovasc Ther. 2004;11(2):132–138.

31.

Theivacumar

Dellagrammaticas

Darwood

Mavor

Gough

. Fate of the great saphenous vein following endovenous laser ablation: does re-canalisation mean recurrence? Eur J Vasc Endovasc Surg. 2008;36(2):211–215.

32.

Theivacumar

Dellagrammaticas

Beale

Mavor

Gough

. Fate and clinical significance of saphenofemoral junction tributaries following endovenous laser ablation of great saphenous vein. Br J Surg. 2007;94(6):722–725.

33.

Theivacumar

Darwood

Gough

. Neovascularisation and recurrence 2 years after varicose vein treatment for sapheno-femoral and great saphenous vein reflux: a comparison of surgery and endovenous laser ablation. Eur J Vasc Endovasc Surg. 2009;38(2):203–207.

34.

Disselhoff

der Kinderen

Kelder

Moll

. Five-year results of a randomised clinical trial of endovenous laser ablation of the great saphenous vein with and without ligation of the saphenofemoral junction. Eur J Vasc Endovasc Surg. 2011;41(5):685–690.